GSVBMFLYZBOZFN-VPSRXSMPSA-N
C26H28F3N5O2S — CID 134398820
Data last refreshed: (MolForge compound catalog, from PubChem)
About GSVBMFLYZBOZFN-VPSRXSMPSA-N
GSVBMFLYZBOZFN-VPSRXSMPSA-N (PubChem CID 134398820) has the molecular formula C26H28F3N5O2S and a molecular weight of 531.60 g/mol. Its IUPAC name is N-phenylsulfanyl-6-[3-[(2R)-2-(trifluoromethyl)cyclopropyl]oxypyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | GSVBMFLYZBOZFN-VPSRXSMPSA-N |
|---|---|
| PubChem CID | 134398820 |
| Molecular Formula | C26H28F3N5O2S |
| Molecular Weight | 531.60 g/mol |
| Exact Mass | 531.19 |
| IUPAC Name | N-phenylsulfanyl-6-[3-[(2R)-2-(trifluoromethyl)cyclopropyl]oxypyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide |
| SMILES | C[C@@H]1CN(c2nc(-n3ccc(OC4C[C@H]4C(F)(F)F)n3)ccc2C(=O)NSc2ccccc2)C(C)(C)C1 |
| InChI | InChI=1S/C26H28F3N5O2S/c1-16-14-25(2,3)33(15-16)23-18(24(35)32-37-17-7-5-4-6-8-17)9-10-21(30-23)34-12-11-22(31-34)36-20-13-19(20)26(27,28)29/h4-12,16,19-20H,13-15H2,1-3H3,(H,32,35)/t16-,19+,20?/m0/s1 |
| InChIKey | GSVBMFLYZBOZFN-VPSRXSMPSA-N |
| XLogP | 5.66 |
| TPSA | 72.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 531.60 |
| LogP ≤ 5 | 5.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134398820 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.